FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308181471> ?p ?o ?g. }

• W4308181471 endingPage "143" @default.
• W4308181471 startingPage "135" @default.
• W4308181471 abstract "Steroidal mineralocorticoid-receptor-antagonists (MRAs), such as spironolactone and eplerenone, are guideline-directed therapies in patients with heart failure with reduced ejection fraction or resistant hypertension. However, the associated risk of hyperkalemia and hormonal side effects limit their broad use and downstream cardiorenal protection in high-risk patients with type 2 diabetes mellitus (T2DM) and moderate-to-advanced chronic kidney disease (CKD). The critical unmet need to improve long-term cardiorenal outcomes in such patients with CKD has sparked considerable efforts to the discovery and development of a new class of compounds. Finerenone is a novel, nonsteroidal MRA that has recently received regulatory approval with the indication of cardiorenal protection in patients with CKD associated with T2DM. Two landmark phase 3 clinical trials, FIDELIO-DKD and FIGARO-DKD, demonstrated that among patients with T2DM and a broad spectrum of CKD, finerenone reduced the risk of hard cardiovascular and kidney failure outcomes as compared with placebo, with a minimal risk of hyperkalemia. Subgroup analyses of these trials also provided preliminary evidence that the efficacy and safety profile of finerenone was similar and irrespective of background therapy with other guideline-directed therapies, such as sodium-glucose co-transporter type 2 (SGLT-2) inhibitors and glucagone-like peptide 1 receptor agonists. Whether the combination of finerenone with a SGLT-2 inhibitor is more beneficial in patients with T2DM and CKD as compared with either therapy alone is a crucial research question that is currently under investigation in an ongoing clinical trial." @default.
• W4308181471 created "2022-11-08" @default.
• W4308181471 creator A5025855476 @default.
• W4308181471 creator A5051708137 @default.
• W4308181471 date "2022-11-04" @default.
• W4308181471 modified "2023-10-13" @default.
• W4308181471 title "The Nonsteroidal Mineralocorticoid-Receptor-Antagonist Finerenone in Cardiorenal Medicine: A State-of-the-Art Review of the Literature" @default.
• W4308181471 cites W1574144538 @default.
• W4308181471 cites W1818378016 @default.
• W4308181471 cites W1830102405 @default.
• W4308181471 cites W2075323044 @default.
• W4308181471 cites W2079169053 @default.
• W4308181471 cites W2104209472 @default.
• W4308181471 cites W2138612646 @default.
• W4308181471 cites W2152072062 @default.
• W4308181471 cites W2152094259 @default.
• W4308181471 cites W2166200293 @default.
• W4308181471 cites W2201994032 @default.
• W4308181471 cites W2277498553 @default.
• W4308181471 cites W2323458614 @default.
• W4308181471 cites W2324541858 @default.
• W4308181471 cites W2332030555 @default.
• W4308181471 cites W2344743510 @default.
• W4308181471 cites W2427094903 @default.
• W4308181471 cites W2535727175 @default.
• W4308181471 cites W2777100344 @default.
• W4308181471 cites W2777409124 @default.
• W4308181471 cites W2791591136 @default.
• W4308181471 cites W2792230432 @default.
• W4308181471 cites W2804041146 @default.
• W4308181471 cites W2883307844 @default.
• W4308181471 cites W2889385457 @default.
• W4308181471 cites W2897424563 @default.
• W4308181471 cites W2908535040 @default.
• W4308181471 cites W2916938080 @default.
• W4308181471 cites W2920171724 @default.
• W4308181471 cites W2982024515 @default.
• W4308181471 cites W2982548907 @default.
• W4308181471 cites W2994812022 @default.
• W4308181471 cites W3093851112 @default.
• W4308181471 cites W3094119455 @default.
• W4308181471 cites W3094152119 @default.
• W4308181471 cites W3094429645 @default.
• W4308181471 cites W3096486083 @default.
• W4308181471 cites W3107151441 @default.
• W4308181471 cites W3110972804 @default.
• W4308181471 cites W3138538004 @default.
• W4308181471 cites W3166864141 @default.
• W4308181471 cites W3170987692 @default.
• W4308181471 cites W3188495695 @default.
• W4308181471 cites W3201633147 @default.
• W4308181471 cites W3204780566 @default.
• W4308181471 cites W3207290141 @default.
• W4308181471 cites W4206077470 @default.
• W4308181471 cites W4206944595 @default.
• W4308181471 cites W4207014647 @default.
• W4308181471 cites W4210377967 @default.
• W4308181471 cites W4214897998 @default.
• W4308181471 cites W4225655571 @default.
• W4308181471 cites W4226143869 @default.
• W4308181471 cites W4226182345 @default.
• W4308181471 cites W4237773453 @default.
• W4308181471 cites W4282925091 @default.
• W4308181471 cites W4293860347 @default.
• W4308181471 doi "https://doi.org/10.1093/ajh/hpac124" @default.
• W4308181471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36331811" @default.
• W4308181471 hasPublicationYear "2022" @default.
• W4308181471 type Work @default.
• W4308181471 citedByCount "5" @default.
• W4308181471 countsByYear W43081814712023 @default.
• W4308181471 crossrefType "journal-article" @default.
• W4308181471 hasAuthorship W4308181471A5025855476 @default.
• W4308181471 hasAuthorship W4308181471A5051708137 @default.
• W4308181471 hasBestOaLocation W43081814711 @default.
• W4308181471 hasConcept C126322002 @default.
• W4308181471 hasConcept C164705383 @default.
• W4308181471 hasConcept C177713679 @default.
• W4308181471 hasConcept C189135053 @default.
• W4308181471 hasConcept C2776379505 @default.
• W4308181471 hasConcept C2778198053 @default.
• W4308181471 hasConcept C2778525890 @default.
• W4308181471 hasConcept C2778653478 @default.
• W4308181471 hasConcept C2780072264 @default.
• W4308181471 hasConcept C2781309322 @default.
• W4308181471 hasConcept C71924100 @default.
• W4308181471 hasConceptScore W4308181471C126322002 @default.
• W4308181471 hasConceptScore W4308181471C164705383 @default.
• W4308181471 hasConceptScore W4308181471C177713679 @default.
• W4308181471 hasConceptScore W4308181471C189135053 @default.
• W4308181471 hasConceptScore W4308181471C2776379505 @default.
• W4308181471 hasConceptScore W4308181471C2778198053 @default.
• W4308181471 hasConceptScore W4308181471C2778525890 @default.
• W4308181471 hasConceptScore W4308181471C2778653478 @default.
• W4308181471 hasConceptScore W4308181471C2780072264 @default.
• W4308181471 hasConceptScore W4308181471C2781309322 @default.
• W4308181471 hasConceptScore W4308181471C71924100 @default.
• W4308181471 hasFunder F4320337338 @default.
• W4308181471 hasIssue "3" @default.

• next